• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,524.26 -719.08
( -0.97%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
63,697.20 -2,890.92
(-4.34%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

ICICI Bank Ltd
Industry :  Banks - Private Sector
BSE Code
ISIN Demat
Book Value()
532174
INE090A01021
461.5408182
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ICICIBANK
18.05
905074.77
EPS(TTM)
Face Value()
Div & Yield %
69.93
2
0.95
 

Supriya Lifescience standalone net profit rises 47.34% in the March 2026 quarter
May 28,2026
Net profit of Supriya Lifescience rose 47.34% to Rs 74.23 crore in the quarter ended March 2026 as against Rs 50.38 crore during the previous quarter ended March 2025. Sales rose 50.20% to Rs 276.53 crore in the quarter ended March 2026 as against Rs 184.11 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.26% to Rs 209.12 crore in the year ended March 2026 as against Rs 187.96 crore during the previous year ended March 2025. Sales rose 18.86% to Rs 827.88 crore in the year ended March 2026 as against Rs 696.49 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales276.53184.11 50 827.88696.49 19
OPM %35.3036.71 -35.5237.44 -
PBDT100.6370.14 43 303.65268.93 13
PBT92.1364.06 44 275.24248.49 11
NP74.2350.38 47 209.12187.96 11